Acknowledgements
Project funding
Ensembl receives majority funding from the Wellcome Trust (grant number WT108749/Z/15/Z) with additional funding for specific project components from the National Human Genome Research Institute (U41HG007823 and 2U41HG007234), the Biotechnology and Biological Sciences Research Council (BB/N019563/1 and BB/M011615/1), Open Targets, the Wellcome Trust (WT104947/Z/14/Z, WT200990/Z/16/Z, WT201535/Z/16/Z, WT108749/Z/15/A, WT212925/Z/18/Z), ELIXIR: the research infrastructure for life-science data, and the European Molecular Biology Laboratory. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n° 733161 (MultipleMS). We also receive funding from the 'Save the Tasmanian Devil Program'.
Funded by Wellcome
Co-funded by the European Union
Previous sources of funding
The Wellcome Trust Sanger Institute was a partner in the Ensembl project until 2016.
EU Framework Programme 6
The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 282510 - BLUEPRINT.
Web image credits
- All animal images on this site are public domain or used with permission of their creators. Please see our image credits page for full details.
- The small icons used in the web interface are derived from the Rocky set by Icon Dock.
- Project logos are used with permission of the relevant organisations